"L'Azienda Socio Sanitaria Territoriale di Cremona comprende i presidi ospedalieri di Cremona e Oglio Po e gli ambiti territoriali di Cremona e Casalmaggiore. L’Azienda persegue i fini istituzionali di tutela e promozione della salute degli individui e della collettività. Gli obiettivi strategici che intende perseguire sono finalizzati alla cura della persona e alla continuità della cura, attraverso percorsi assistenziali che sostengano l’attività di cura e che valorizzino il ruolo dei professionisti, e, contestualmente, attraverso la caratterizzazione dei presidi ospedalieri aziendali e la rete territoriale in ottica integrata."

During the past decade, Farmacia, Azienda Socio Sanitaria Territoriale di Cremona conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Farmacia, Azienda Socio Sanitaria Territoriale di Cremona" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Farmacia, Azienda Socio Sanitaria Territoriale di Cremona" are "Cancer of the Prostate" (2 trials), "Prostate Cancer" (2 trials), "Hormone Sensitive Prostate Cancer" (1 trials) and "Nonmetastatic Castration-Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Farmacia, Azienda Socio Sanitaria Territoriale di Cremona" in a lesser frequency.

Most popular intervention types in "Farmacia, Azienda Socio Sanitaria Territoriale di Cremona" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (2 trials), "Placebo" (2 trials) and "Leuprolide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Farmacia, Azienda Socio Sanitaria Territoriale di Cremona" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Farmacia, Azienda Socio Sanitaria Territoriale di Cremona". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Farmacia, Azienda Socio Sanitaria Territoriale di Cremona, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Farmacia, Azienda Socio Sanitaria Territoriale di Cremona, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".